NCT07142525

Brief Summary

This study is designed to compare two common techniques for reducing the nasal hump during rhinoplasty: the traditional method using osteotomes and rasps, and a newer technique called hybrid osteoplasty that uses a surgical drill. Both approaches aim to improve the appearance and function of the nose. The trial will measure pain, swelling, bruising, and the smoothness of the nasal bridge, as well as patient satisfaction and breathing outcomes. Participants will be followed for one year to assess both early healing and long-term results.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Oct 2025Dec 2026

First Submitted

Initial submission to the registry

August 19, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 26, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

1.2 years

First QC Date

August 19, 2025

Last Update Submit

September 27, 2025

Conditions

Keywords

OsteoplastyDorsal HumpRhinoplasty

Outcome Measures

Primary Outcomes (7)

  • Mean Change in Rhinoplasty Outcome Evaluation (ROE) Score from Baseline to 12 Months

    ROE (Rhinoplasty Outcome Evaluation) questionnaire scored 0-100 (higher = greater satisfaction). Score calculated per instrument guidance from the 6 items, converted to 0-100. Change is 12-month minus preoperative score.

    Baseline (preoperative) and 12 months post-operation.

  • Mean Dorsal Contour Irregularity Score on Blinded Photographic Assessment at 12 Months

    Standardized 7-view photographs rated by three blinded surgeons using a 4-point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe irregularity). Primary analysis compares group means; inter-rater agreement assessed.

    12 months post-operation.

  • Mean Periorbital Edema Score on 4-Point Clinician Scale at Day 1 and Day 7

    3 Clinicians-rated 4-point edema scale (0 = none, 1 = mild, 2 = moderate, 3 = severe).

    Post-op Day 1 and Day 7.

  • Mean Periorbital Ecchymosis Score on 4-Point Clinician Scale at Day 1 and Day 7

    3 Clinician-rated 4-point ecchymosis scale (0-3).

    Post-op Day 1 and Day 7.

  • Proportion of Participants with Residual Hump or Dorsal Depression on Blinded Photographic Assessment at 12 Months

    Blinded photographic assessment for remnant hump or depression (present/absent), by 3 assessors.

    12 months post-operation

  • Proportion of Participants with Nasal Dorsum Width Symmetry at 12 Months

    Symmetry rated by 3 blinded assessors on 3-point scale (symmetric / mildly asymmetric / asymmetric)

    12 months post-operation

  • Number of Participants Requiring Unplanned Revision Surgery within 12 Months

    Any unplanned surgical revision related to the nasal dorsum

    Within 12 months post-operation

Secondary Outcomes (4)

  • Proportion of Participants with Smooth Nasal Dorsum (Non-Blinded Binary Assessment) at 12 Months

    12 months post-operation

  • Mean Change in Nasal Obstruction Symptom Evaluation (NOSE) Score from Baseline to 12 Months

    Baseline (preoperative) and 12 months post-operation.

  • Mean Pain Score on 0-10 Visual Analogue Scale at Post-Op Day 0 and Day 7

    Post-op Day 0 and Day 7

  • Proportion of Participants with Palpable or Visible Dorsal Callus on Clinical Exam at 3 and 6 Months

    3 and 6 months post-operation

Study Arms (2)

Hybrid Osteoplasty

EXPERIMENTAL

Participants undergo dorsal hump reduction using a surgical burr (drill) without traditional dorsal osteotomy. The technique allows controlled bone contouring under direct visualization.

Procedure: Hybrid Osteoplasty

Traditional Osteotomy and Rasping

ACTIVE COMPARATOR

Participants undergo dorsal hump reduction using the conventional method of osteotomy combined with rasping. This is the established standard approach for contouring the nasal dorsum.

Procedure: Traditional Osteotomy and Rasping

Interventions

Open rhinoplasty with dorsal hump reduction performed using a powered surgical burr under irrigation and direct visualization. Bone is contoured gradually to achieve a smooth dorsum while preserving the keystone area. No dorsal osteotomy is performed in this arm. Cartilaginous work and adjunctive steps (e.g., septoplasty or tip refinement) are performed as clinically indicated but are not part of the intervention being tested.

Also known as: Drill-Assisted Dorsal Hump Reduction, Power-Assisted Osteoplasty, Burr Osteoplasty
Hybrid Osteoplasty

Open rhinoplasty using the conventional technique for dorsal hump reduction. The bony hump is resected with a straight osteotome, followed by manual rasping to refine the nasal dorsum, with preservation of the keystone area. Powered burrs are not used for primary dorsal contouring in this arm. Cartilaginous work and adjunctive procedures may be performed as clinically indicated but are not part of the tested intervention.

Also known as: Osteotome + Rasp Technique, Conventional Dorsal Hump Reduction
Traditional Osteotomy and Rasping

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary open rhinoplasty planned.
  • Dorsal hump with bony or mixed component suitable for either technique.
  • No prior nasal surgery or significant nasal trauma affecting dorsum.
  • ASA I-III and fit for general anesthesia.
  • Willing to provide written informed consent, including standardized photography.
  • Able and willing to attend all follow-up visits through 12 months.

You may not qualify if:

  • Revision rhinoplasty or prior osteotomy/osseocartilaginous work.
  • Active infection, open lesions, or uncontrolled dermatologic conditions at operative field.
  • Bleeding diathesis, platelet disorder, INR elevation, or anticoagulant/antiplatelet therapy that cannot be paused.
  • Uncontrolled systemic disease (e.g., hypertension, diabetes) or ASA ≥ IV.
  • Pregnancy or breastfeeding.
  • Chronic isotretinoin use within past 6 months or long-term systemic corticosteroid use.
  • Concurrent interventional study that may affect healing or outcomes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Hospital

Sulaymaniyah, KRI, 46001, Iraq

Location

Related Publications (12)

  • Azizli E, Bayar Muluk N, Dundar R, Cingi C. A new preservation technique for dehumping the dorsum. Eur Rev Med Pharmacol Sci. 2023 Mar;27(2 Suppl):57-62. doi: 10.26355/eurrev_202303_31703.

    PMID: 36971222BACKGROUND
  • Ferreira MG, Monteiro D, Reis C, Almeida e Sousa C. Spare Roof Technique: A Middle Third New Technique. Facial Plast Surg. 2016 Feb;32(1):111-6. doi: 10.1055/s-0035-1570503. Epub 2016 Feb 10.

    PMID: 26862972BACKGROUND
  • Aldosari BF, Alhajress RI, Bogari AO. Hump Rasping Using Powered Instruments: A Retrospective Review. Plast Reconstr Surg Glob Open. 2024 Sep 10;12(9):e6153. doi: 10.1097/GOX.0000000000006153. eCollection 2024 Sep.

    PMID: 39258281BACKGROUND
  • Lal GN, Ghosh P. Use of drill in rhinoplasty (a case report). Indian J Otolaryngol Head Neck Surg. 1999 Jan;51(1):90-2. doi: 10.1007/BF02996859.

    PMID: 23119498BACKGROUND
  • Goodman WS. The rotating burr in rhinoplasty. Arch Otolaryngol. 1981 Jul;107(7):436-8. doi: 10.1001/archotol.1981.00790430038010. No abstract available.

    PMID: 7247809BACKGROUND
  • Avashia YJ, Marshall AP, Allori AC, Rohrich RJ, Marcus JR. Decision-Making in Middle Vault Reconstruction following Dorsal Hump Reduction in Primary Rhinoplasty. Plast Reconstr Surg. 2020 Jun;145(6):1389-1401. doi: 10.1097/PRS.0000000000006850.

    PMID: 32195860BACKGROUND
  • Barrett DM, Casanueva F, Wang T. Understanding Approaches to the Dorsal Hump. Facial Plast Surg. 2017 Apr;33(2):125-132. doi: 10.1055/s-0037-1598033. Epub 2017 Apr 7.

    PMID: 28388791BACKGROUND
  • Fuller JC, Hilger PA. Modified Skoog Method for Hump Reduction. Facial Plast Surg Clin North Am. 2021 Feb;29(1):131-139. doi: 10.1016/j.fsc.2020.09.008.

    PMID: 33220838BACKGROUND
  • Sowder JC, Thomas AJ, Gonzalez CD, Limaye NS, Ward PD. Use of Spreader Flaps Without Dorsal Hump Reduction and the Effect on Nasal Function. JAMA Facial Plast Surg. 2017 Jul 1;19(4):287-292. doi: 10.1001/jamafacial.2016.2057.

    PMID: 28241228BACKGROUND
  • Azizzadeh B, Reilly M. Dorsal Hump Reduction and Osteotomies. Clin Plast Surg. 2016 Jan;43(1):47-58. doi: 10.1016/j.cps.2015.09.022. Epub 2015 Oct 23.

    PMID: 26616694BACKGROUND
  • Roostaeian J, Unger JG, Lee MR, Geissler P, Rohrich RJ. Reconstitution of the nasal dorsum following component dorsal reduction in primary rhinoplasty. Plast Reconstr Surg. 2014 Mar;133(3):509-518. doi: 10.1097/01.prs.0000438453.29980.36.

    PMID: 24263393BACKGROUND
  • Rohrich RJ, Muzaffar AR, Janis JE. Component dorsal hump reduction: the importance of maintaining dorsal aesthetic lines in rhinoplasty. Plast Reconstr Surg. 2004 Oct;114(5):1298-308; discussion 1309-12. doi: 10.1097/01.prs.0000135861.45986.cf.

    PMID: 15457053BACKGROUND

Study Officials

  • Goran L Omer, PhD

    University of Sulaimani

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 19, 2025

First Posted

August 26, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) underlying the published results will be shared, including baseline demographic information, surgical technique allocation, intraoperative variables, and postoperative outcome measures (pain scores, edema, ecchymosis, ROE scores, NOSE scores, blinded photographic assessments, and revision status). Data will be available in de-identified form upon reasonable request to the principal investigator after publication of the primary results. Supporting documents, including the study protocol and statistical analysis plan, will also be made available.

Time Frame
IPD and supporting information will be available beginning after publication of the primary study results and will remain available for a minimum of 5 years thereafter.
Access Criteria
De-identified IPD and supporting documents will be made available to qualified researchers affiliated with academic institutions or recognized research organizations. Requests must include a methodologically sound proposal and will be reviewed by the principal investigator. Approved requestors will be required to sign a data use agreement ensuring compliance with ethical and confidentiality standards. Data will be provided in de-identified format via secure transfer.

Locations